Clinical Trial Update: A Study of LY3007113 in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for LY3007113 in participants with advanced/metastatic cancer; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LY3007113

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2018-08-07